Cecilia Guillermo-Esposito, Patricia Casais, Gabriela Cesarman-Maus, Fernanda Andrade-Orsi, Rosario Martínez-Rovira, Joao C de-Campos-Guerra, Suely M Rezende, Raúl Izaguirre-Ávila, Raúl Altman, José Ceresetto, Cecilia Colorio, Cristina Duboscq, Claudio Martín Rosa, Soledad Molnar, Diana García, Mario Luis Tejarina, Nelson Nina García, Juan Choque Pacheco, Chiara Chindamo J. María, Gloria Ramos Ramos, Guillermo León Basantes, Aura Milena Reyna, Miriam Cantero Guevara, Mateo Porres Aguilar, Luis Meillón, Flavio Adrián Grimaldo, Ludwing Alexander Bacon Fonseca, Al Ávila Milord, Ricardo Aguilar, Rafael Aparicio, Paula de Guggiari, Gloria Chumpitaz, Pedro Pablo García, Blanca Steffano, Sandra Damiano, Juan Serrano, Marisol Zavahra
Coagulopathy and thrombosis associated with coronavirus disease 2019 (COVID-19) represent a major issue in the management of this disease. In the past months, clinical studies have demonstrated that COVID-19 patients present with a particular hypercoagulable state, in which a markedly increased D-dimer concomitant with increased levels of fibrinogen are observed. This hypercoagulable state leads to an increased risk of thrombosis, which seems to be higher among those patients with critical symptoms of COVID-19...
December 20, 2021: Archivos de Cardiología de México